Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol (original) (raw)

Abstract

Background: It has been suggested that asthmatic subjects with persisting symptoms despite adequate maintenance therapy should be systematically evaluated to identify factors contributing to poor control. The aims of this study were to examine the prevalence of these factors in a cohort of sequentially referred poorly controlled asthmatics, and to determine if any factor or combination of factors predicted true therapy resistant asthma (TRA).

Methods: Patients were evaluated using a systematic evaluation protocol including induced sputum analysis, psychiatric assessment, ear, nose and throat examination, pulmonary function testing, high resolution CT scan of the thorax, and 24 hour dual probe ambulatory oesophageal pH monitoring; any identified provoking factor was treated. Asthma was managed according to BTS guidelines.

Results: Of 73 subjects who completed the assessment, 39 responded to intervention and 34 had TRA. Subjects with TRA had a greater period of instability, a higher dose of inhaled steroids at referral, more rescue steroid use, and a lower best percentage forced expiratory volume in 1 second (FEV1%). Oesophageal reflux, upper airway disease, and psychiatric morbidity were common (57%, 95%, 49%, respectively) but were not more prevalent in either group. Using multivariate logistic regression analysis, inhaled steroid dose >2000 µg BDP, previous assessment by a respiratory specialist, and initial FEV1% of <70% at referral predicted a final diagnosis of TRA.

Conclusions: In poorly controlled asthmatics there is a high prevalence of co-morbidity, identified by detailed systematic assessment, but no difference in prevalence between those who respond to intervention and those with TRA. Targeted treatment of identified co-morbidities has minimal impact on asthma related quality of life in those with therapy resistant disease.

Full Text

The Full Text of this article is available as a PDF (148.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Pedersen S., Busse W. W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1–53. doi: 10.1164/ajrccm.157.3.157315. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J., Woolcock A. J. Difficult asthma. Eur Respir J. 1998 Nov;12(5):1209–1218. doi: 10.1183/09031936.98.12051209. [DOI] [PubMed] [Google Scholar]
  3. Chung K. F., Godard P., Adelroth E., Ayres J., Barnes N., Barnes P., Bel E., Burney P., Chanez P., Connett G. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J. 1999 May;13(5):1198–1208. doi: 10.1034/j.1399-3003.1999.13e43.x. [DOI] [PubMed] [Google Scholar]
  4. Irwin R. S., Curley F. J., French C. L. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest. 1993 Jun;103(6):1662–1669. doi: 10.1378/chest.103.6.1662. [DOI] [PubMed] [Google Scholar]
  5. Johnston B. T., McFarland R. J., Collins J. S., Love A. H. Symptom index as a marker of gastro-oesophageal reflux disease. Br J Surg. 1992 Oct;79(10):1054–1055. doi: 10.1002/bjs.1800791022. [DOI] [PubMed] [Google Scholar]
  6. Juniper E. F., Guyatt G. H., Ferrie P. J., Griffith L. E. Measuring quality of life in asthma. Am Rev Respir Dis. 1993 Apr;147(4):832–838. doi: 10.1164/ajrccm/147.4.832. [DOI] [PubMed] [Google Scholar]
  7. Juniper E. F., Guyatt G. H., Willan A., Griffith L. E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994 Jan;47(1):81–87. doi: 10.1016/0895-4356(94)90036-1. [DOI] [PubMed] [Google Scholar]
  8. Little Stuart A., MacLeod Kirsten J., Chalmers George W., Love Janet G., McSharry Charles, Thomson Neil C. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med. 2002 Apr 15;112(6):446–452. doi: 10.1016/s0002-9343(02)01047-1. [DOI] [PubMed] [Google Scholar]
  9. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5–40. [PubMed] [Google Scholar]
  10. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  11. ten Brinke A., Zwinderman A. H., Sterk P. J., Rabe K. F., Bel E. H. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001 Sep 1;164(5):744–748. doi: 10.1164/ajrccm.164.5.2011026. [DOI] [PubMed] [Google Scholar]